The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews.

Ryan Pelletier Kelvin Ng Wajd AlkabbaniYoussef LabibNicolas MouradJohn-Michael Gamble

Published in: Endocrinology, diabetes & metabolism (2020)

It appears that SGLT-2 inhibitors are not associated with an increased risk of total cancer or specific cancers in patients with type 2 diabetes. However, higher quality evidence is needed to derive confident conclusions.

Keyphrases

papillary thyroid
squamous cell
systematic review
childhood cancer
lymph node metastasis
high resolution
randomized controlled trial
squamous cell carcinoma
young adults